Enliven Therapeutics
ELVN
ELVN
74 hedge funds and large institutions have $781M invested in Enliven Therapeutics in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 3 closing their positions.
Holders
74
Holders Change
+12
Holders Change %
+19.35%
% of All Funds
1.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
16
Increased
25
Reduced
22
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
5VM
1
5AM Venture Management
San Francisco,
California
|
$67.5M |
| 2 |
2
Morgan Stanley
New York
|
$1.11M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$20.8M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$41.4M |
| 5 |
5
BlackRock
New York
|
$31.9M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
C
77
Covestor
London,
United Kingdom
| $0 | 1 | – | – |
|
|
CFGS
78
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
79
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 4 | +4 | New |
|